Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. - Wikidata - wikimedia - TriplyDB

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

http://www.wikidata.org/entity/Q35408930

about

Mucosal-associated invariant T cells from induced pluripotent stem cells: A novel approach for modeling human diseases Mucosal-associated invariant T cells in autoimmunity, immune-mediated diseases and airways disease Mucosal-Associated Invariant T Cells in Multiple Sclerosis: The Jury is Still Out Regulation of Lipid Specific and Vitamin Specific Non-MHC Restricted T Cells by Antigen Presenting Cells and Their Therapeutic Potentials Early innate responses to pathogens: pattern recognition by unconventional human T-cells iNKT and MAIT Cell Alterations in Diabetes MAIT cells: new guardians of the liver Gut microbiota and immune crosstalk in metabolic disease Gut permeability, its interaction with gut microflora and effects on metabolic health are mediated by the lymphatics system, liver and bile acid.Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.Mucosal-associated invariant T cell-rich congenic mouse strain allows functional evaluation.MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.Interleukin-17A Gene Expression in Morbidly Obese Women.HIV-Infected Children Have Lower Frequencies of CD8+ Mucosal-Associated Invariant T (MAIT) Cells that Correlate with Innate, Th17 and Th22 Cell Subsets.Macrophage functions in lean and obese adipose tissue.Mucosa-Associated Invariant T Cells Are Systemically Depleted in Simian Immunodeficiency Virus-Infected Rhesus Macaques.Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor.Human MAIT-cell responses to Escherichia coli: activation, cytokine production, proliferation, and cytotoxicity Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells Development of a diet-induced murine model of diabetes featuring cardinal metabolic and pathophysiological abnormalities of type 2 diabetes.Enhanced immune response of MAIT cells in tuberculous pleural effusions depends on cytokine signaling.Adipocytes, like their progenitors, contribute to inflammation of adipose tissues through promotion of Th-17 cells and activation of monocytes, in obese subjects.Maternal obesity drives functional alterations in uterine NK cells.Does bariatric surgery improve adipose tissue function?Activation status of mucosal-associated invariant T cells reflects disease activity and pathology of systemic lupus erythematosus.The complex immunological and inflammatory network of adipose tissue in obesity.Adipose tissue inflammation in the pathogenesis of type 2 diabetes.MAIT cells accumulate in placental intervillous space and display a highly cytotoxic phenotype upon bacterial stimulation.MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?The role of mucosal-associated invariant T cells in infectious diseases.Immunologic impact of the intestine in metabolic disease.Liver inflammation and fibrosis.Shared and Distinct Phenotypes and Functions of Human CD161++ Vα7.2+ T Cell Subsets.Intra-hepatic Depletion of Mucosal Associated Invariant T cells in Hepatitis C Virus-induced Liver Inflammation.[Gut microbiota and immune crosstalk in metabolic disease].Nonreversible MAIT cell-dysfunction in chronic hepatitis C virus infection despite successful interferon-free therapy.Peripheral invariant natural killer T cell deficiency in metabolically unhealthy but normal weight versus metabolically healthy but obese individuals Weight loss independent changes in adipose tissue macrophage and T cell populations after sleeve gastrectomy in mice A Novel Mouse Model of iNKT Cell-deficiency Generated by CRISPR/Cas9 Reveals a Pathogenic Role of iNKT Cells in Metabolic Disease.

P2860

Q26750384-6C2238F5-0B66-4FAF-A482-DDBA607CC979 Q26771558-4F2ACCAD-5EF0-4B13-A155-F5F11D7B3B6A Q26781518-E7C54AE1-7988-467B-AF4B-F890DAEFD049 Q26797333-A35EC376-35CA-4AED-9B1B-91E568E375A4 Q26800118-104ED540-4A49-42ED-B957-B85A5FCF7DB9 Q26801962-BE66B1B3-8468-4343-8A6A-0C10AFD05DC2 Q28073095-E41C10B2-4DCA-4146-BEC5-B23093255D4D Q28078180-D3074CD0-B4B3-4674-83F6-A15718FBC6D0 Q35733648-3B0FC01B-23D0-450D-96FD-F68B56419354 Q35815577-D98E5E0B-2D74-4F7C-8B2F-B7461CB9F8DE Q35829274-034D26A2-4E75-457A-A3B4-0849AFA154E0 Q35847725-C325A3C5-71B7-4CBB-933F-054053F07558 Q36088476-E486EDC8-35DB-4FCD-986F-4F6FEFF332BB Q36112685-F6C22CD2-2533-41A6-B824-5EDF3B17BEB8 Q36412774-8731FB96-95A0-4B18-A80C-AA4528471872 Q36811942-2BEC2B2E-1D9C-4BAB-B39C-C3BB5716A5C8 Q37046424-161218EB-B748-49C8-84FC-E889D53C098E Q37098070-26B1BF34-47C6-4A66-AC7C-175FDD1E5C00 Q37101168-D25F087F-70FC-4E93-9013-B18485DD8E87 Q37216788-0E681F22-6F02-43D9-BABF-E7D7D0C81BF0 Q37227889-D4D9DFDC-A18F-4658-B26D-B49491A85D3B Q37237976-18A9731A-969E-425C-813E-D7FE509E40CF Q37277292-A4C23F55-A6A0-48C7-91AB-A6AD17405946 Q37669778-97657508-7A1D-4349-859A-908164289B33 Q37697841-F56FA748-FEEB-470C-BE94-BE297641546B Q38578953-8F698C7C-C70B-4B71-9ECA-8A8C2335D13E Q38587715-58B8FF64-B81E-4EF2-B403-3A00BB635FDF Q38667181-839834FE-E34B-4C02-B0E5-5097D480ABF0 Q38869734-E3110C5D-55A0-4A71-B513-81778DF11A62 Q38890712-0E47CE4B-8960-46BE-A831-DF40449AEBC3 Q38955495-BE314D13-F310-4661-B976-41DA23BC3632 Q39065615-EB274D9E-E975-4DC9-91E8-A4975FE09041 Q39065620-AA242AD8-E4D1-4626-B221-4DCEBE4F992F Q40044893-0D2F54B2-7938-4CE6-81B5-6EA77B282CE4 Q40093638-249EDCFB-1BC8-4C16-9722-ADCA716FD908 Q40145683-F508A60F-4644-41CE-ACD0-91DC3670D546 Q40703746-AC3191C3-B8EC-48DA-8959-BFEDA6AF8EF9 Q42006127-8CE30EBF-9E14-487D-8C3F-D27F0112BAFD Q42293671-4F10DD3E-BD2A-40A8-B282-92FB52DA83C3 Q42371813-BCAA0204-9F17-4BEC-8537-B14A2BCBA6A0

P2860

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

http://www.wikidata.org/entity/Q35408930

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@ast

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@en

type

label

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@ast

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@en

prefLabel

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@ast

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@en

P1433

Q35408930-F0C61DDF-0769-4DA2-81C5-68A12FC3D62A

P1476

Q35408930-82328518-E39B-4829-A6AB-C78F50B46FC1

P2093

Q35408930-09B15A9B-5BD1-4C96-8617-99DDEFCBE692

Q35408930-25463855-EA1D-4900-B7BA-60694465B3A3

Q35408930-2F0D0C4B-96D1-4DE5-993B-8A30B0F15E74

Q35408930-32752ADC-B69B-4B2D-BB2A-1388E4CB7DC7

Q35408930-339885EF-FA3A-47DA-A177-DBDC917F27F0

Q35408930-6A62045D-B2F9-4427-9774-6DB036E802E1

Q35408930-833C700E-2291-4FEB-BBA1-CC495B3203D6

Q35408930-885194E9-CF88-422A-8460-B299FC559EB9

Q35408930-9713009F-5BE9-495B-960E-EC81EB77599E

Q35408930-9A73A25A-8563-480D-ABE5-81C981EB7DC3

P2860

Q35408930-011D096E-B4BF-4F51-9576-8142616AECCC

Q35408930-0534EE60-DEBE-46D1-BB73-5C3BDF26D703

Q35408930-0EC76812-4DF4-4A86-9FD8-670D966269FB

Q35408930-16BEC3EF-613C-4937-8F32-9DA4FE25B184

Q35408930-18BC6652-CE1E-4EB6-9536-D9CD4027D14E

Q35408930-21DE5A79-0B88-466C-A9A1-BDF94BAF2F05

Q35408930-3D869029-955F-4336-B790-BBA1BBCF8402

Q35408930-3F669C3B-9DFA-472B-AD07-0F34E0A01322

Q35408930-44CA0491-A43F-47D5-97B3-94BB553701DC

Q35408930-4B00325C-BC16-4693-B5E2-6C9C8D1AA950

P304

Q35408930-3162D754-7D12-494B-AF5B-7B150620F9AF

P31

Q35408930-F30D1D90-2DF1-46E6-8F2E-051932470253

P356

Q35408930-6F11D878-703C-4381-BE25-65394E450F84

P407

Q35408930-F2F392EC-6848-475C-8648-ECABB67EC721

P433

Q35408930-91EBB71F-A4CC-4190-B62E-E2D2BA0A0E52

P478

Q35408930-3D1C3398-E8FD-429B-BAA6-FFCD019C13D2

P50

Q35408930-21B6EAE7-3D5A-4F45-85F1-CB261E3860B7

Q35408930-3612103B-E8C1-4CC5-B3BA-D74314B65CED

Q35408930-43CDE39E-D0D5-455D-82DF-3331CFA0753D

Q35408930-46E275D1-B054-478A-B4B8-01BDD125242D

Q35408930-855EE5F3-BAC8-4DB1-8E53-9E2FFCE40E3A

Q35408930-BC71B1FF-5B43-42C2-87AB-A0A6082028EF

Q35408930-CAE1D1BA-359D-436F-9625-FB1678EBBF51

Q35408930-CF1C181D-1BCB-4D4B-9A21-C1A0822A7C50

Q35408930-EA69414E-511A-4D3A-A0A1-7F068E924CD2

P577

Q35408930-FF3F5492-735C-4260-B924-32E3D935E139

P698

Q35408930-112C80AD-47BB-485E-9D93-01D41F7F78B0

P921

Q35408930-EFEA6DC2-2063-4BB0-87C6-F8068E3D6960

P932

Q35408930-B17E1FC0-BA6F-41C0-9CB7-6BF299CD7174

P356

P1433

Journal of Clinical Investigation

P1476

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

@en

P2093

Adriana Torcivia

http://www.w3.org/2001/XMLSchema#string

Agnès Lehuen

http://www.w3.org/2001/XMLSchema#string

Badr Kiaf

http://www.w3.org/2001/XMLSchema#string

Christine Poitou

http://www.w3.org/2001/XMLSchema#string

Etienne Larger

http://www.w3.org/2001/XMLSchema#string

Jennifer Da Silva

http://www.w3.org/2001/XMLSchema#string

Judith Aron-Wisnewsky

http://www.w3.org/2001/XMLSchema#string

Karine Pingris

http://www.w3.org/2001/XMLSchema#string

Lars Kjer-Nielsen

http://www.w3.org/2001/XMLSchema#string

Laurent Genser

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties

Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

MR1 presents microbial vitamin B metabolites to MAIT cells

Recognition of vitamin B metabolites by mucosal-associated invariant T cells

T-cell activation by transitory neo-antigens derived from distinct microbial pathways

Microbial ecology: human gut microbes associated with obesity

A metagenome-wide association study of gut microbiota in type 2 diabetes

Human gut microbiota in obesity and after gastric bypass

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

Metagenome and metabolism: the tissue microbiota hypothesis.

P304

1752-1762

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI78941

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

James McCluskey

Christian Boitard

Isabelle Magalhaes

Nicolas Venteclef

Karine Clément

P577

2015-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25751065

http://www.w3.org/2001/XMLSchema#string

P921

P932

4396481

http://www.w3.org/2001/XMLSchema#string